Aldose reductase inhibitors: recent developments.
Sarges
R
R
Pfizer Central Research, Groton, Connecticut 06340.
Oates
P J
PJ
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D000818:Animals; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000188:drug therapy; D003929:Diabetic Neuropathies / Q000188:drug therapy; D003930:Diabetic Retinopathy / Q000188:drug therapy; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans
D004791:Enzyme Inhibitors; D000449:Aldehyde Reductase